All follow-up (admission–week 8) | At admission | Weeks 1–2 | Weeks 3–8 | P value* | |
Children receiving ≥1 prescription, no (%) | |||||
Any medication | 1790 (74.6) | 1293 (53.9) | 786 (32.8) | 758 (31.6) | <0.01 |
Antibiotic | 720 (30.0) | 184 (7.7) | 272 (11.3) | 356 (14.8) | <0.01 |
Injectable | 3 (0.1) | 0 (0.0) | 1 (0.0) | 2 (0.1) | 0.37 |
Oral | 284 (11.8) | 2 (0.1) | 118 (4.9) | 185 (7.7) | <0.01 |
Amoxicillin | 247 (10.3) | 0 (0.0) | 99 (4.1) | 162 (6.8) | <0.01 |
Local | 509 (21.2) | 182 (7.6) | 164 (6.8) | 200 (8.3) | 0.15 |
Anti-inflammatory/analgesic | 15 (0.6) | 2 (0.1) | 6 (0.3) | 8 (0.3) | 0.17 |
Antihistamine | 5 (0.2) | 1 (0.0) | 2 (0.1) | 2 (0.1) | 0.82 |
Antimalarial | 1358 (56.6) | 1135 (47.3) | 122 (5.1) | 291 (12.1) | <0.01 |
Antipyretic/analgesic | 1058 (44.1) | 710 (29.6) | 212 (8.8) | 343 (14.3) | <0.01 |
Injectable corticosteroid | 5 (0.2) | 0 (0.0) | 2 (0.1) | 4 (0.2) | 0.14 |
Iron folic acid | 421 (17.5) | 13 (0.5) | 344 (14.3) | 185 (7.7) | <0.01 |
Local antifungal, antiparasitic, antiseptic | 181 (7.5) | 51 (2.1) | 67 (2.8) | 88 (3.7) | <0.01 |
Oral antifungal | 84 (3.5) | 19 (0.8) | 43 (1.8) | 31 (1.3) | <0.01 |
Oral antiparasitic, antiprotozoan | 4 (0.2) | 0 (0.0) | 3 (0.1) | 1 (0.0) | 0.17 |
Oral rehydration solution | 9 (0.4) | 2 (0.1) | 5 (0.2) | 2 (0.1) | 0.37 |
Other medications | 4 (0.2) | 0 (0.0) | 2 (0.1) | 2 (0.1) | 0.37 |
Prescribed medications received, mean (SD) | 2.01 (1.90) | 0.88 (0.93) | 0.47 (0.79) | 0.66 (1.22) | <0.01 |
Prescribed medications per visit, mean (SD) | 1.12 (0.80) | 0.88 (0.94) | 0.42 (0.67) | 0.46 (0.76) | <0.01 |
*P values derived from Χ2 test (categorical outcomes) and one-way ANOVA (continuous outcomes).
ANOVA, analysis of variance; SAM, severe acute malnutrition.